PD15 Defining molecular markers of endocrine resistance in clinic Komal Jhaveri

Reprogramming Breast Cancer Risk in Utero via Endocrine Disruptor and Dietary Fat InteractionПодробнее

Translational Science Forum: "ER+ word salad decoded: SERD, SERM, SERCA, CERAN, PROTAC"Подробнее

Diagnosing Cancer in 15 Minutes or Less -Cause/Action: Raj Krishnan at TEDxSanDiego 2012Подробнее

Germline Positive in Breast Cancer | Dr Sewanti LimayeПодробнее

Frontline Therapy in HR-Positive Breast CancerПодробнее

Dr. Komal Jhaveri | Translational Controversies | San Antonio Breast Cancer Symposium 2022Подробнее

The Risks of Incomplete Cancer Information from Non-Medical Influencers | Dr. Jamal A. KhanПодробнее

CDK4/6 Plus Endocrine Therapy as First-Line ApproachПодробнее

MPN Molecular Biology - Dr. Jyoti NangaliaПодробнее

Potential trends in the molecular profiling of breast cancerПодробнее

Indian Experience on molecular oncology in breast cancer - The 5th virtual scientific meetingПодробнее

Future Direction of Molecular and Personalized Medicine in Breast CancerПодробнее

What I Tell My Patients: Hormonal Therapy for Hormone Receptor-Positive Breast CancerПодробнее

How a biopsy for cancer diagnosis is done | With help of potato | Dr. Gaurav GangwaniПодробнее